xen12019-sup-0001-FigS1.docxWord document171KFigure S1. Schema describing the process used to create double knockout cells and fetuses.
xen12019-sup-0002-FigS2.jpgimage/jpg677KFigure S2. Analyses of CMAH Gene Disruptions.
xen12019-sup-0003-FigS3.jpgimage/jpg443KFigure S3. Wild type and double-KO liver derived porcine cells stained with (a) anti-Neu5Gc antibody (cyan), appropriate isotype control antibody and (b) IB4 lectin (red).
xen12019-sup-0004-FigS4.jpgimage/jpg468KFigure S4. Individual curves for antibody mediated complement dependent cytotoxicity of 10 healthy human serum samples against GGTA1-KO (red) and double-KO (blue) PBMCs.
xen12019-sup-0005-FigS5.jpgimage/jpg646KFigure S5. Antibody binding and antibody-mediated complement-dependent cytotoxicity assays.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.